Adherium appoints new CEO to drive global growth

Adherium Limited recently announced the appointment of Arik Anderson as Group Chief Executive Officer (CEO).

With over 25 years of experience in the medical technology and medical device manufacturing industries, Anderson has led significant growth for emerging technology companies. Previously, he was Senior Vice President, R&D and Operations, and General Manager at Somanetics from 2007 until the company’s integration with Covidien was completed in 2011.

He has also served as Director of Product Development at Delphi Medical Systems. In addition, he was President and Chief Executive Officer of Tasso Solutions, a product development and manufacturing consulting firm.

Sutherland, Adherium Founder said, "Adherium is very fortunate to attract someone of Arik’s standing, he is ideally suited to lead the company into its commercial growth phase as we focus on expanding our global footprint.  We welcome him to our team, his industry experience, combined with our award-winning Smartinhaler products and technology platform, will allow Adherium to further build upon its position as a market leader in the digital health space. His arrival will also allow me more time to focus on areas of new product development that I have been wanting to undertake for some time now."

Anderson said, "Adherium’s digital health solutions are already having a positive impact on the health of people with respiratory disease globally. I look forward to leading the organization to bring the benefits of Smartinhaler™ to patients world-wide."

Tom Lynch, Adherium Chairman, said: "Arik will be a strong leader for our business arriving at a key time as our products and services experience significant and rising global demand."